Adjuvant Colon Cancer With ELOXatin/5 FU Based Regimen: ACCELOX.

Trial Profile

Adjuvant Colon Cancer With ELOXatin/5 FU Based Regimen: ACCELOX.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Mar 2016

At a glance

  • Drugs Fluorouracil (Primary) ; Oxaliplatin (Primary)
  • Indications Colon cancer
  • Focus Therapeutic Use
  • Acronyms ACCELOX
  • Most Recent Events

    • 24 Feb 2016 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 15 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top